State of New Jersey Common Pension Fund D trimmed its holdings in Doximity, Inc. (NASDAQ:DOCS – Free Report) by 17.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 54,137 shares of the company’s stock after selling 11,075 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in Doximity were worth $2,359,000 at the end of the most recent reporting period.
Several other large investors have also recently added to or reduced their stakes in DOCS. LRI Investments LLC bought a new position in shares of Doximity in the first quarter worth $27,000. Farther Finance Advisors LLC lifted its holdings in Doximity by 324.2% in the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock worth $34,000 after purchasing an additional 603 shares during the period. Blue Trust Inc. grew its position in Doximity by 621.4% in the 2nd quarter. Blue Trust Inc. now owns 1,385 shares of the company’s stock valued at $37,000 after buying an additional 1,193 shares in the last quarter. Quarry LP increased its stake in Doximity by 101.2% during the 2nd quarter. Quarry LP now owns 1,616 shares of the company’s stock valued at $45,000 after buying an additional 131,253 shares during the period. Finally, DekaBank Deutsche Girozentrale bought a new stake in shares of Doximity during the 1st quarter worth about $46,000. 87.19% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
DOCS has been the subject of several recent analyst reports. Raymond James reiterated an “outperform” rating and issued a $65.00 price objective (up from $37.00) on shares of Doximity in a report on Friday, November 8th. Barclays increased their price target on Doximity from $52.00 to $75.00 and gave the company an “overweight” rating in a research note on Monday. Evercore ISI boosted their price objective on Doximity from $34.00 to $45.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. Needham & Company LLC raised Doximity from a “hold” rating to a “buy” rating and set a $38.00 target price for the company in a research note on Friday, August 9th. Finally, Bank of America lifted their target price on Doximity from $32.00 to $45.00 and gave the stock a “neutral” rating in a report on Monday, October 7th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $48.14.
Doximity Stock Performance
Doximity stock opened at $52.88 on Thursday. The company has a 50 day moving average price of $42.48 and a 200 day moving average price of $33.68. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $61.75. The firm has a market capitalization of $9.82 billion, a price-to-earnings ratio of 60.78, a P/E/G ratio of 5.08 and a beta of 1.30.
Doximity Profile
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
See Also
- Five stocks we like better than Doximity
- Want to Profit on the Downtrend? Downtrends, Explained.
- Rocket Lab is the Right Stock for the Right Time
- What Are Dividend Contenders? Investing in Dividend Contenders
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- How to Invest in the Best Canadian Stocks
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS – Free Report).
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.